The global diagnostic biomarker market is anticipated to grow at a considerable CAGR of 12.9% during the forecast period. The rising pervasiveness of chronic diseases is one of the prime factors affecting and driving the market. Chronic diseases include such as heart disease, cancer, diabetes, stroke, and arthritis among others that are affecting people across the globe. Rise in chronic diseases is also increasing the requirement and generating the need for research and development of diagnostic biomarker.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/diagnostic-biomarker-market
The key players operating in the global diagnostic biomarker market had been adopting strategy such as new launches to gain major market share. For instance, in April 2021, one of the global medical technology company Siemens Healthineers had undergone through a strategic agreement with a company providing proteomics solutions for dry discovery and development name as biognosys. With the support of this agreement both the companies would be offering customers with novel biomarkers with the means of HRM technology.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered-
o By Application
o By Diagnostic Technique
o By End-User
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Abbott, F. Hoffmann-La Roche Ltd, Merck KgaA, SIGNOSIS INC., and QIAGEN
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Diagnostic Biomarker Market – Segmentation
By Application
- Oncology
- Cardiology
- Neurology
- Nephrology
- Other
By Diagnostic Technique
- Elisa
- Colorimetric Assay
- Liquid Chromatography-Mass Spectrometry
- Particle-Enhanced Turbidimetric Immunoassay
- Other
By End-User
- Hospitals & Diagnostic Labs
- Research Centers
A full report of Diagnostic Biomarker Market is available at: https://www.omrglobal.com/industry-reports/diagnostic-biomarker-market
Diagnostic Biomarker Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Abbott
- Astellas Pharma Inc.
- Astute Medical, In
- Avacta Life Sciences Ltd.
- BANYAN BIOMARKERS
- Bayer AG
- Beckman Coulter, Inc
- Biodesix
- Biomarker Technologies, Inc.
- bioMerieux SA
- BioPorto A/S
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
